Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices

التفاصيل البيبلوغرافية
العنوان: Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices
المؤلفون: Denis Raccah, Yannis Préau, Sébastien Galie, Pauline Schaepelynck, Martine Armand
المساهمون: Centre de résonance magnétique biologique et médicale (CRMBM), Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Centre National de la Recherche Scientifique (CNRS), Service Nutrition & Diabète, Hôpital Ste Marguerite, APHM, Hôpital Sainte-Marguerite [CHU - APHM] (Hôpitaux Sud )
المصدر: Diabetes Technology and Therapeutics
Diabetes Technology and Therapeutics, 2020, ⟨10.1089/dia.2020.0515⟩
Diabetes Technology and Therapeutics, Mary Ann Liebert, 2020, ⟨10.1089/dia.2020.0515⟩
Diabetes Technology & Therapeutics
بيانات النشر: Mary Ann Liebert Inc, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Adult, Blood Glucose, Pediatrics, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Intermittently scanned continuous glucose monitoring, Hypoglycemia, 03 medical and health sciences, 0302 clinical medicine, Endocrinology, Diabetes mellitus, Real-time continuous glucose monitoring, Humans, Hypoglycemic Agents, Medicine, 030212 general & internal medicine, Glycemic variability, Glycated Hemoglobin, Type 1 diabetes, business.industry, Continuous glucose monitoring, Blood Glucose Self-Monitoring, Insulin sensitivity, Original Articles, medicine.disease, 3. Good health, Medical Laboratory Technology, Diabetes Mellitus, Type 1, Cohort, Observational study, France, Diabetic patient, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
الوصف: International audience; Aim: Assess the impact of switching from intermittently scanned (FreeStyle Libre [FSL]) to real-time (Dexcom G4 platinum [DG4]) continuous glucose monitoring systems on glycemia control in type 1 diabetes (T1D) patients with high risk of hypoglycemia and/or elevated glycated hemoglobin (HbA1c). Methods: We conducted an observational study in 18 T1D adults with poor glycemic control on FSL. Ambulatory glucose profile data were collected during the last 3 months of FSL use before inclusion (M0 period), during the first 3 months (M3 period) and the last 3 months (M6 period) of DG4 use. Data were then expressed as 24-h averages. Biological HbA1c was measured for all three periods. Patients were their own-controls and statistics were performed using paired t-test or Wilcoxon for matched-pairs. Results: The switch to DG4 at M3 resulted in a higher time-in-range (TIR) 70-180 mg/dL (median [Q1;Q3], 53.1 [44.5;67.3] vs. 41.5 [28.5;62.0], P = 0.0008), and a lower time-below-range
تدمد: 1557-8593
1520-9156
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb267daed232a011025b55cb023ec5b0Test
https://doi.org/10.1089/dia.2020.0515Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....fb267daed232a011025b55cb023ec5b0
قاعدة البيانات: OpenAIRE